FdaApplication
NDA 202100
Identifiers
- fda_app_no: NDA202100
Properties
| Property | Value |
|---|---|
| applicant_name | NEXTWAVE PHARMACEUTICALS INC A SUB OF TRIS PHARMA INC |
| application_type | NDA |
| approval_date | 2012-09-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| QUILLIVANT XR | METHYLPHENIDATE HYDROCHLORIDE | 5MG/ML | FOR SUSPENSION, EXTENDED RELEASE;ORAL |
1 product